Ozempic / GLP-1 Gastroparesis (Stomach Paralysis) — Updates

Every change, with a date and a source. That's the whole point.

Full changelog

Updated Oct 3, 2026New case (Oct 2026, US): Ozempic/GLP-1 gastroparesis — stomach-injury claims (gastroparesis, obstruction, pancreatitis) active in state and federal courts; FDA class labeling updated; no MDL on the public record (per firm pages and FDA).

Last updated: today

← Back to Ozempic / GLP-1 Gastroparesis (Stomach Paralysis)